Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
RICHMOND, Va. — A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and ...
Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound ...
High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...
The Fred Hutchinson Cancer Center recently added irreversible electroporation (IRE) to its slate of focal therapy offerings and is the only cancer center in the region to offer IRE, high-intensity ...
Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...
MERIDIAN, Idaho — A new, less invasive prostate cancer treatment is now available through the Idaho Urologic Institute. It is called the High-Intensity Focused Ultrasound, or HIFU for short. It uses ...
A study recently published in The Prostate externally validated multiple biochemical recurrence definitions to predict treatment outcomes among patients with localized prostate cancer (PCa) following ...
Routine prostate cancer screenings save lives, yet some men still avoid them. However, making the process more streamlined increases the likelihood that men will get the tests they need to catch ...
Sponsored FOY Math Professor Back in Class After Beating Prostate Cancer Desai Sethi Urology Institute Offers HIFU Procedure Minimizing Side Effects When Will Neris was diagnosed with prostate cancer ...